CLINICAL_TRIALS
research
· 2025-08-19
Clinical Trial Update: A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management [EARLY_Phase 1]
Summary
This early Phase 1 trial evaluates a novel medical system that quantitatively diagnoses and guides personalized botulinum neurotoxin injections for chronic pelv…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HillMed Inc. | Conditions: Interstitial Cystitis, Chronic Pain | EARLY_Phase 1 | Status: NOT_YET_RECRUITING